Project Grant K99GM162992
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded UC San Diego a $249,000 Project Grant effective September 1, 2025, through August 31, 2028, under the Biomedical Research and Research Training program (CFDA 93.859). The award supports fundamental research investigating how biophysical cues—including mechanical confinement, matrix properties, and cellular morphology—regulate macrophage and T-cell behavior in tumor microenvironments. The research...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of California, San Diego a $479,738 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) beginning May 1, 2026 and concluding April 30, 2031. The research focuses on advancing understanding of kinetochore machinery function in accurate genome inheritance during cell division and investigating chromosome segregation mechanisms in embryonic development....
- Federal Project Grant Award Summary The University of California, San Diego received a $526,805 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2026, through May 31, 2030. The award supports development of episomal single-cell reporter assays designed to enable researchers to measure the activity of hundreds to thousands of regulatory elements with tissue-specific...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded University of California, Davis a $432,417 Project Grant effective April 1, 2026, through January 31, 2031, under the Biomedical Research and Research Training program (CFDA 93.859). This award funds research investigating the role of linear and nonlinear mechanical forces in regulating cellular metabolism through extracellular matrix (ECM) interactions. The project delivers fundamental...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Regents of the University of California, San Francisco a $158,240 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) on March 5, 2026, with completion targeted for November 30, 2027. The research investigates the mechanical properties and molecular mechanisms governing E-cadherin-mediated cell-cell contact formation, specifically examining how mechanical...
- Federal Project Grant Award Summary The University of California, San Diego received a $370,550 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded May 1, 2026, with completion targeted for February 28, 2031. The award funds research to develop the Intracellular Protein Organization Landscape (IPOL), a quantitative computational framework designed to characterize cell types and states...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $124,767 to the University of California, San Francisco under the Biomedical Research and Research Training program (CFDA 93.859) effective May 1, 2026 through April 30, 2028. This Project Grant supports de novo protein design research focused on creating proteins that bind small molecules and catalyze chemical reactions. The research builds on the principal investigator's recent success designing...
- Grant Award Summary The University of California, San Diego received a $654,038 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded July 25, 2025, with a completion date of April 30, 2030. The grant supports fundamental research addressing how single cells transform into fully formed, functional organisms through a biophysical framework titled "Flows, Fates and Forces: A...
- Federal Project Grant Award Summary The University of California, San Diego received a $440,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), with an award date of July 1, 2026 and completion deadline of February 28, 2031. The research focuses on developing multiscale biophysical computational tools and conducting molecular dynamics simulations to elucidate how lipid-protein interactions...
- Summary of Federal Grant Award Yale University received a $125,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective February 1, 2026 through January 31, 2028. This award supports investigator-initiated fundamental biomedical research aimed at increasing understanding of biological processes and laying the foundation for advances in disease diagnosis, treatment, and prevention. The...
The National Institute of General Medical Sciences (NIGMS) awarded UC San Diego a $125,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) for the period July 1, 2026 through June 30, 2028. This award supports research investigating the biophysical mechanisms of bidirectional coupling between mechanotransduction and cell morphology. The project examines how cells respond and adapt to biochemical and physical environmental cues, with particular emphasis on nuclear translocation of mechanotransduction regulatory proteins such as yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) in response to substrate nanotopography and G protein-coupled receptor (GPCR) activation. During the K99 phase of the project, UC San Diego will deliver experimental research and computational modeling outputs quantifying cell and nuclear deformation responses. Research activities include immunofluorescence imaging studies of cytoskeletal activation and YAP/TAZ localization in human osteosarcoma cell lines (U2OS) exposed to nanopillar substrates with and without the GPCR agonist angiotensin II, biosensor-based fluorescence imaging of GPCR activation in live cells, and finite-element-based computational simulations integrating biochemical signaling dynamics with cell mechanics and membrane curvature data. Findings will advance understanding of how cells integrate physical and chemical environmental signals through intracellular signaling events.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $125.0k | 6/22/26 |